Clinical Trial Update: Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated Alpha-1 Antitrypsin (AAT) plus corticosteroids versus corticosteroids alone for graft-versus-host disease in hematopoietic stem cell t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Alpha-1 Antitrypsin (AAT) (alpha-1 antitrypsin)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: CSL Behring | Conditions: Graft Versus Host Disease (GVHD) | Phase 3 | Status: COMPLETED | Results posted: 2025-08-29